Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
By R. Pauwels, S. Pedersen, W. Busse, W. Tan, Yu-zhi Chen, S. Ohlsson, A. Ullman, C. Lamm, P. O'Byrne. The Lancet, 2003
715 citations recorded by the source corpus.
Subfields: Physiology, Pulmonary and Respiratory Medicine, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/a23d834dff25ba81ca51b188e20ec8aa64417d0c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. Reddel
- E. D. Bateman
- H. Kerstjens
- L. Boulet
- P. Chanez
- M. Partridge
- William W. Busse
- Homer A. Boushey
Citations in the corpus
- External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? (2006, neutral): “7 There were 215 individual references in the relevant chapter of the GINA guidelines from which 17 qualifying RCTs were identified and included in the analysis (Figure 2).(13-29) The characteristics of the included RCTs are given in Table 2.”
- Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007, neutral): “The START study (Pauwels et al. 2003) enrolled 7,241 subjects, 5–66 years of age, who had mild asthma of less than 2 years’ duration, according to each subject’s report.”
- An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. (2009, background): “Although severe exacerbations are more common with poorly controlled asthma (52), they also occur in patients with otherwise mild (27) or well-controlled asthma (60).”